GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biotage AB (OTCPK:BITGF) » Definitions » Purchase Of Business

Biotage AB (Biotage AB) Purchase Of Business : $0.0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Biotage AB Purchase Of Business?

Biotage AB's purchase of business for the three months ended in Mar. 2024 was $0.0 Mil. It means Biotage AB spent $0.0 Mil on purchasing business. Biotage AB's purchase of business for the trailing twelve months (TTM) ended in Mar. 2024 was $0.0 Mil.

Compared with last quarter ($0.0 Mil in Dec. 2023 ), Biotage AB spent the same money on purchasing business in Mar. 2024 ($0.0 Mil).


Biotage AB Purchase Of Business Historical Data

The historical data trend for Biotage AB's Purchase Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotage AB Purchase Of Business Chart

Biotage AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Purchase Of Business
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.19 - -31.02 -1.16 -

Biotage AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Purchase Of Business Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Biotage AB Purchase Of Business Calculation

The amount used to purchase business.

Purchase Of Business for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biotage AB Purchase Of Business Related Terms

Thank you for viewing the detailed overview of Biotage AB's Purchase Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.


Biotage AB (Biotage AB) Business Description

Traded in Other Exchanges
Address
Vimpelgatan 5, Box 8, Uppsala, SWE, 751 03
Biotage AB provides separation technology and solutions for analytical and organic chemistry from research to commercial analytical laboratories and industrial applications. Its customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research, and contract manufacturers as well as clinical, forensic, and academic laboratories in addition to organizations focused on food safety, clean water, and environmental sustainability. It serves three geographic markets: The Americas, APAC (Asia-Pacific,) and EMEA (Europe, Middle East & Africa). The company's product areas include Small Molecules & Synthetic Therapeutics, Biologics & Advanced Therapeutics, Scale-Up, Diagnostics, Analytical Testing, and Water & Environmental Testing.

Biotage AB (Biotage AB) Headlines

From GuruFocus

Berenberg Bank is now covering Biotage AB (publ) (BIOT)

By PRNewswire PRNewswire 06-29-2021

Biotage appoints Nomination Committee

By PRNewswire PRNewswire 09-24-2020

Biotage AB (publ) publishes new Financial Goals

By PRNewswire PRNewswire 03-14-2022

Biotage AB (publ) Year-End report January - December 2020

By PRNewswire PRNewswire 02-12-2021

Biotage moves to the large cap segment

By PRNewswire PRNewswire 01-03-2022

Biotage AB (publ) appoints new CFO

By PRNewswire PRNewswire 07-01-2021